| Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ... Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 2012 | 820 | 2012 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 596 | 2015 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 323 | 2015 |
| Doxycycline, an inhibitor of mitochondrial biogenesis, effectively reduces cancer stem cells (CSCs) in early breast cancer patients: a clinical pilot study C Scatena, M Roncella, A Di Paolo, P Aretini, M Menicagli, G Fanelli, ... Frontiers in oncology 8, 452, 2018 | 129 | 2018 |
| Genetic alterations in hereditary breast cancer G Cipollini, S Tommasi, A Paradiso, P Aretini, F Bonatti, I Brunetti, ... Annals of oncology 15, i7-i13, 2004 | 100 | 2004 |
| KLF4 is a novel candidate tumor suppressor gene in pancreatic ductal carcinoma F Zammarchi, M Morelli, M Menicagli, C Di Cristofano, K Zavaglia, ... The American journal of pathology 178 (1), 361-372, 2011 | 99 | 2011 |
| Angiogenesis and VEGF expression in pre‐invasive lesions of the human breast P Viacava, AG Naccarato, G Bocci, G Fanelli, P Aretini, A Lonobile, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2004 | 81 | 2004 |
| BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants A Tazzite, H Jouhadi, S Nadifi, P Aretini, E Falaschi, A Collavoli, ... Gynecologic oncology 125 (3), 687-692, 2012 | 74 | 2012 |
| Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations F Marroni, P Aretini, E D’Andrea, MA Caligo, L Cortesi, A Viel, E Ricevuto, ... Journal of medical genetics 41 (4), 278-285, 2004 | 70 | 2004 |
| Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations F Marroni, P Aretini, E D'Andrea, MA Caligo, L Cortesi, A Viel, E Ricevuto, ... European Journal of Human Genetics 12 (11), 899-906, 2004 | 68 | 2004 |
| Detection of the BRAFV600E Mutation in Fine Needle Aspiration Cytology of Thyroid Papillary Microcarcinoma Cells Selected by Manual Macrodissection: An … I Marchetti, G Iervasi, CM Mazzanti, F Lessi, S Tomei, AG Naccarato, ... Thyroid 22 (3), 292-298, 2012 | 65 | 2012 |
| RNA-based analysis of BRCA1 and BRCA2 gene alterations F Bonatti, C Pepe, M Tancredi, G Lombardi, P Aretini, E Sensi, E Falaschi, ... Cancer genetics and cytogenetics 170 (2), 93-101, 2006 | 65 | 2006 |
| Laser capture microdissection and RNA-seq analysis: High sensitivity approaches to explain histopathological heterogeneity in human glioblastoma FFPE archived tissues P Civita, S Franceschi, P Aretini, V Ortenzi, M Menicagli, F Lessi, ... Frontiers in oncology 9, 482, 2019 | 61 | 2019 |
| CXCL 12α/SDF‐1 from perisynaptic Schwann cells promotes regeneration of injured motor axon terminals S Negro, F Lessi, E Duregotti, P Aretini, M La Ferla, S Franceschi, ... EMBO molecular medicine 9 (8), 1000-1010, 2017 | 60 | 2017 |
| The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management F Panebianco, C Mazzanti, S Tomei, P Aretini, S Franceschi, F Lessi, ... Bmc Cancer 15, 1-11, 2015 | 59 | 2015 |
| A yeast recombination assay to characterize human BRCA1 missense variants of unknown pathological significance MA Caligo, F Bonatti, L Guidugli, P Aretini, A Galli Human mutation 30 (1), 123-133, 2009 | 58 | 2009 |
| Papillary lesions of the breast: a molecular progression? CD Cristofano, K Mrad, K Zavaglia, G Bertacca, P Aretini, G Cipollini, ... Breast cancer research and treatment 90, 71-76, 2005 | 53 | 2005 |
| Human saliva as route of inter-human infection for mouse mammary tumor virus CM Mazzanti, F Lessi, I Armogida, K Zavaglia, S Franceschi, M Al Hamad, ... Oncotarget 6 (21), 18355, 2015 | 52 | 2015 |
| High level of messenger RNA for BRMS1 in primary breast carcinomas is associated with poor prognosis G Lombardi, C Di Cristofano, A Capodanno, MC Iorio, P Aretini, P Isola, ... International journal of cancer 120 (6), 1169-1178, 2007 | 48 | 2007 |
| Whole-exome analysis in osteosarcoma to identify a personalized therapy C Chiappetta, M Mancini, F Lessi, P Aretini, V De Gregorio, C Puggioni, ... Oncotarget 8 (46), 80416, 2017 | 47 | 2017 |
